Patent · US Active

Combination of a protein kinase inhibitor and an additional chemotherapeutic agent

US11246929B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Lars Damstrup · Maribo, DK
Thomas Grombacher · Reinheim, DE
Christian Sirrenberg · Darmstadt, DE
Lyubomir Vassilev · Bedford, US
Astrid Zimmermann · Konstanz, DE

Key dates

Filing date	Dec 18, 2017
Grant date	Feb 15, 2022
Priority date	—
Expiry date	Dec 18, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Combination therapy for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.